GSK launches shingles vaccine, Shingrix in India
Express Pharma
APRIL 24, 2023
GlaxoSmithKline Pharmaceuticals (GSK) announced the launch of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in India, for the prevention of shingles (herpes zoster) and post-herpetic neuralgia in adults aged 50 years and above. Shingles cause a painful rash.
Let's personalize your content